GFR α-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways

Journal of Neurochemistry

Volumn 115, Issue 3, 2010, Pages 707-715

  Pruett, Brandon S ^a   Salvatore, Michael F ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Dopamine; GDNF family receptor 1; Glial cell line derived neurotrophic factor; Mesoaccumbens; Nigrostriatal; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

AGE; AGING; ANIMAL TISSUE; ARTICLE; BRADYKINESIA; CONTROLLED STUDY; CORPUS STRIATUM; IN VIVO STUDY; MALE; MESOACCUMBENS SYSTEM; NERVE TRACT; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

AGING; ANIMALS; BLOTTING, WESTERN; CORPUS STRIATUM; DOPAMINE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; IMMUNOGLOBULIN FC FRAGMENTS; KINETICS; MALE; MOTOR ACTIVITY; MUTANT CHIMERIC PROTEINS; NEURAL PATHWAYS; NUCLEUS ACCUMBENS; RATS; RATS, INBRED BN; RATS, INBRED F344; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 78651335607     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06963.x     Document Type: Article

References (47)

1. Andersson D. R., Nissbrandt H. and Bergquist F. (2006) Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission. Eur. J. Neurosci. 24, 617-624.
2. Aoi M., Date I., Tomita S. and Ohmoto T. (2000) The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Neurosci. Res. 36, 319-325.
3. Besset V., Scott R. P. and Ibanez C. F. (2000) Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275, 39159-39166.
4. Boger H. A., Middaugh L. D., Huang P., Zaman V., Smith A. C., Hoffer B. J., Tomac A. C. and Granholm A. C. (2006) A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp. Neurol. 202, 336-347.
5. Boger H. A., Middaugh L. D., Zaman V., Hoffer B. and Granholm A. C. (2008) Differential effects of the dopamine neurotoxin MPTP in animals with a partial deletion of the GDNF receptor, GFR alpha1, gene. Brain Res. 1241, 18-28.
6. Cao J. P., Wang H. J., Yu J. K., Yang H., Xiao C. H. and Gao D. S. (2008) Involvement of NCAM in the effects of GDNF on the neurite outgrowth in the dopamine neurons. Neurosci. Res. 61, 390-397.
7. Collier T. J., Dung L. Z., Carvey P. M., Fletcher-Turner A., Yurek D. M., Sladek J. R. Jr and Kordower J. H. (2005) Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism. Exp. Neurol. 191(Suppl. 1), S60-S67.
8. Connor B., Kozlowski D. A., Unnerstall J. R., Elsworth J. D., Tillerson J. L., Schallert T. and Bohn M. C. (2001) Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration. Exp. Neurol. 169, 83-95.
9. Dass B., Kladis T., Chu Y. and Kordower J. H. (2006) RET expression does not change with age in the substantia nigra pars compacta of rhesus monkeys. Neurobiol. Aging 27, 857-861.
10. Franke B., Figiel M. and Engele J. (1998) CNS glia are targets for GDNF and neurturin. Histochem. Cell Biol. 110, 595-601.
11. Gash D. M., Zhang Z., Ovadia A. et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
12. Georgievska B., Kirik D. and Bjorklund A. (2004) Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J. Neurosci. 24, 6437-6445.
13. Gerhardt G. A., Cass W. A., Huettl P., Brock S., Zhang Z. and Gash D. M. (1999) GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys. Brain Res. 817, 163-171.
14. Gill S. S., Patel N. K., Hotton G. R., O'Sullivan K., McCarter R., Bunnage M., Brooks D. J., Svendsen C. N. and Heywood P. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat. Med. 9, 589-595.
15. Grondin R., Zhang Z., Yi A., Cass W. A., Maswood N., Andersen A. H., Elsberry D. D., Klein M. C., Gerhardt G. A. and Gash D. M. (2002) Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125, 2191-2201.
16. Grondin R., Cass W. A., Zhang Z., Stanford J. A., Gash D. M. and Gerhardt G. A. (2003) Glial cell line-derived neurotrophic factor increases stimulus-evoked dopamine release and motor speed in aged rhesus monkeys. J. Neurosci. 23, 1974-1980.
17. Haycock J. W., Ahn N. G., Cobb M. H. and Krebs E. G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl. Acad. Sci. U S A 89, 2365-2369.
18. Hebert M. A. and Gerhardt G. A. (1997) Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J. Pharmacol. Exp. Ther. 282, 760-768.
19. Hoffer B. J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L. F. and Gerhardt G. A. (1994) Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182, 107-111.
20. Honda S., Nakajima K., Nakamura Y., Imai Y. and Kohsaka S. (1999) Rat primary cultured microglia express glial cell line-derived neurotrophic factor receptors. Neurosci. Lett. 275, 203-206.
21. Jing S., Wen D., Yu Y. et al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113-1124.
22. Lindgren N., Leak R. K., Carlson K. M., Smith A. D. and Zigmond M. J. (2008) Activation of the extracellular signal-regulated kinases 1 and 2 by glial cell line-derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease. J. Neurosci. Res. 86, 2039-2049.
23. Matsuo A., Nakamura S. and Akiguchi I. (2000) Immunohistochemical localization of glial cell line-derived neurotrophic factor family receptor alpha-1 in the rat brain: Confirmation of expression in various neuronal systems. Brain Res. 859, 57-71.
24. Mijatovic J., Airavaara M., Planken A., Auvinen P., Raasmaja A., Piepponen T. P., Costantini F., Ahtee L. and Saarma M. (2007) Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra. J. Neurosci. 27, 4799-4809.
25. Nozaki C., Asai N., Murakami H., Iwashita T., Iwata Y., Horibe K., Klein R. D., Rosenthal A. and Takahashi M. (1998) Calciumdependent Ret activation by GDNF and neurturin. Oncogene 16, 293-299.
26. Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R. and Ibanez C. F. (2001) Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 29, 171-184.
27. Paratcha G., Ledda F. and Ibanez C. F. (2003) The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 113, 867-879.
28. Pascual A., Hidalgo-Figueroa M., Piruat J. I., Pintado C. O., Gomez- Diaz R. and Lopez-Barneo J. (2008) Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat. Neurosci. 11, 755-761.
29. Ponzio F., Calderini G., Lomuscio G., Vantini G., Toffano G. and Algeri S. (1982) Changes in monoamines and their metabolite levels in some brain regions of aged rats. Neurobiol. Aging 3, 23-29.
30. Remy S., Naveilhan P., Brachet P. and Neveu I. (2001) Differential regulation of GDNF, neurturin, and their receptors in primary cultures of rat glial cells. J. Neurosci. Res. 64, 242-251.
31. Robertson G. S. and Robertson H. A. (1989) Evidence that L-dopainduced rotational behavior is dependent on both striatal and nigral mechanisms. J. Neurosci. 9, 3326-3331.
32. Salvatore M. F., Waymire J. C. and Haycock J. W. (2001) Depolarization- stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ. J. Neurochem. 79, 349-360.
33. Salvatore M. F., Zhang J. L., Large D. M. et al. (2004) Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J. Neurochem. 90, 245-254.
34. Salvatore M. F., Pruett B. S., Spann S. L. and Dempsey C. (2009a) Aging reveals a role for nigral tyrosine hydroxylase ser31 phosphorylation in locomotor activity generation. PLoS ONE 4, e8466.
35. Salvatore M. F., Gerhardt G. A., Dayton R. D., Klein R. L. and Stanford J. A. (2009b) Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system. Exp. Neurol. 219, 197-207.
36. Sarabi A., Hoffer B. J., Olson L. and Morales M. (2001) GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area. J. Comp. Neurol. 441, 106-117.
37. Serra M. P., Quartu M., Mascia F., Manca A., Boi M., Pisu M. G., Lai M. L. and Del F. M. (2005) Ret, GFRalpha-1, GFRalpha-2 and GFRalpha-3 receptors in the human hippocampus and fascia dentata. Int. J. Dev. Neurosci. 23, 425-438.
38. Slevin J. T., Gerhardt G. A., Smith C. D., Gash D. M., Kryscio R. and Young B. (2005) Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102, 216-222.
39. Spangler E. L., Waggie K. S., Hengemihle J., Roberts D., Hess B. and Ingram D. K. (1994) Behavioral assessment of aging in male Fischer 344 and brown Norway rat strains and their F1 hybrid. Neurobiol. Aging 15, 319-328.
40. Stanford J. A., Salvatore M. F., Joyce B. M., Zhang H., Gash D. M. and Gerhardt G. A. (2007) Bilateral effects of unilateral intrastriatal GDNF on locomotor-excited and nonlocomotor-related striatal neurons in aged F344 rats. Neurobiol. Aging 28, 156-165.
41. The UniProt Consortium (2010) The Universal Protein Resource (Uni- Prot) in 2010. Nucleic Acids Res. 38, D142-D148.
42. Thompson L. H., Grealish S., Kirik D. and Bjorklund A. (2009) Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur. J. Neurosci. 30, 625-638.
43. Treanor J. J., Goodman L., de S. F. et al. (1996) Characterization of a multicomponent receptor for GDNF. Nature 382, 80-83.
44. Trevitt J. T., Carlson B. B., Nowend K. and Salamone J. D. (2001) Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH 23390 in the rat. Psychopharmacology (Berl) 156, 32-41.
45. Xiao H., Hirata Y., Isobe K. and Kiuchi K. (2002) Glial cell line-derived neurotrophic factor up-regulates the expression of tyrosine hydroxylase gene in human neuroblastoma cell lines. J. Neurochem. 82, 801-808.
46. Yurek D. M., Hipkens S. B., Hebert M. A., Gash D. M. and Gerhardt G. A. (1998) Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid rats. Brain Res. 791, 246-256.
47. Zaman V., Boger H. A., Granholm A. C., Rohrer B., Moore A., Buhusi M., Gerhardt G. A., Hoffer B. J. and Middaugh L. D. (2008) The nigrostriatal dopamine system of aging GFRalpha-1 heterozygous mice: neurochemistry, morphology and behavior. Eur. J. Neurosci. 28, 1557-1568.